Clinical Trials Logo

Clinical Trial Summary

This study is intended to demonstrate the non-inferiority of a Duramesh closure as compared to a polydioxanone closure for early surgical site events (SSE) (< 1 month), and Duramesh superiority to polydioxanone for the development of incisional hernia by 1 year for a laparotomy closure.


Clinical Trial Description

This clinical investigation is designed to compare laparotomy closure with Duramesh to closure using PDS. The primary outcome is SSE that occurs within 1 month after surgery. Secondary outcomes that will be studied include device performance and technical success of the index-procedure, hernia occurrence/recurrence noted at 12 months after surgery, SSE and re-interventions that occur within 12 months of surgery, pain, implant palpability/sensation, surgeon and patient satisfaction, and quality of life. ;


Study Design


NCT number NCT05804136
Study type Interventional
Source University Hospital, Ghent
Contact Dorien Haesen, PhD
Phone +32 11 28 69 48
Email dorien.haesen@archerresearch.eu
Status Recruiting
Phase N/A
Start date March 31, 2023
Completion date September 30, 2026